Darbepoetin AlfaIts Use in Anemia Associated with Chronic Kidney Disease

被引：0
作者：
Dean M. Robinson
Stephanie E. Easthope
机构：
[1] Adis International Inc.,
来源：
BioDrugs | 2005年 / 19卷
关键词：
Chronic Kidney Disease; Peritoneal Dialysis; Chronic Kidney Disease Patient; Darbepoetin Alfa; rhEPO Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：327 / 343
页数：16
相关论文
共 50 条
  • [31] Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study
    Franz Schaefer
    Bernd Hoppe
    Therese Jungraithmayr
    Günter Klaus
    Lars Pape
    Mourad Farouk
    Janet Addison
    Nick Manamley
    Karel Vondrak
    Pediatric Nephrology, 2016, 31 : 443 - 453
  • [32] Anemia and the heart in chronic kidney disease
    Zalunardo, Nadia
    Levin, Adeera
    SEMINARS IN NEPHROLOGY, 2006, 26 (04) : 290 - 295
  • [33] Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease
    Chen, Han-Hsiang
    Tarng, Der-Cherng
    Lee, Kun-Feng
    Wu, Chih-Jen
    Chen, Yi-Chou
    JOURNAL OF NEPHROLOGY, 2008, 21 (04) : 543 - 549
  • [34] Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study
    Schaefer, Franz
    Hoppe, Bernd
    Jungraithmayr, Therese
    Klaus, Guenter
    Pape, Lars
    Farouk, Mourad
    Addison, Janet
    Manamley, Nick
    Vondrak, Karel
    PEDIATRIC NEPHROLOGY, 2016, 31 (03) : 443 - 453
  • [35] Drug Use in Chronic Kidney Disease
    Sari, Funda
    Ersoy, Fettah Fevzi
    TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2016, 25 : 1 - 10
  • [36] Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
    Shubhadeep D. Sinha
    Vamsi Krishna Bandi
    Bala Reddy Bheemareddy
    Pankaj Thakur
    Sreenivasa Chary
    Kalpana Mehta
    Vikranth Reddy Pinnamareddy
    Rajendra Pandey
    Subhramanyam Sreepada
    Santosh Durugkar
    BMC Nephrology, 20
  • [37] Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
    Sinha, Shubhadeep D.
    Bandi, Vamsi Krishna
    Bheemareddy, Bala Reddy
    Thakur, Pankaj
    Chary, Sreenivasa
    Mehta, Kalpana
    Pinnamareddy, Vikranth Reddy
    Pandey, Rajendra
    Sreepada, Subhramanyam
    Durugkar, Santosh
    BMC NEPHROLOGY, 2019, 20 (1)
  • [38] Increased NGAL level associated with iron store in chronic kidney disease with anemia
    Daijun Xiang
    Xiuying Wang
    Peipei Liu
    Yuling Pan
    Qian Zhang
    Xiuping Chi
    Ying Jing
    Xinxin Duan
    Qiaozhen Wei
    Jianan Wang
    Mianyang Li
    Chengbin Wang
    Clinical and Experimental Medicine, 2018, 18 : 563 - 568
  • [39] Increased NGAL level associated with iron store in chronic kidney disease with anemia
    Xiang, Daijun
    Wang, Xiuying
    Liu, Peipei
    Pan, Yuling
    Zhang, Qian
    Chi, Xiuping
    Jing, Ying
    Duan, Xinxin
    Wei, Qiaozhen
    Wang, Jianan
    Li, Mianyang
    Wang, Chengbin
    CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 18 (04) : 563 - 568
  • [40] Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients
    Luthi J.-C.
    Flanders W.D.
    Burnier M.
    Burnand B.
    McClellan W.M.
    BMC Nephrology, 7 (1)
12345